RecruitingOBSERVATIONAL

E²-RADIatE: EORTC-ESTRO RADiotherapy InfrAstrucTure for Europe

The E²-RADIatE study is a big European project gathering information from cancer patients who are receiving radiotherapy. Radiotherapy is a common cancer treatment that uses high-energy rays to destroy cancer cells. This study aims to help researchers understand more about how radiotherapy is used in real-world situations, how effective it is, and how it fits in with other cancer treatments. By collecting this information, they hope to improve future radiotherapy treatments and ensure that people with cancer receive the best possible care. It's a long-term study that will follow patients over time, but it doesn't involve giving new treatments or making changes to your care.

At a glance

Status

Recruiting

Sponsor

European Organisation for Research and Treatment of Cancer - EORTC

Enrolment target

2,000

Start

24 Jun 2019

Estimated completion

30 Apr 2026

Cancer

What is this study about?

The E²-RADIatE study is a large-scale project across Europe designed to collect important information from cancer patients. If you have been diagnosed with cancer and your medical team has planned for you to have radiotherapy, this study might be relevant. Radiotherapy is a treatment that uses powerful energy beams to kill cancer cells, and it's a key part of cancer care for many people.

The main goal of this study is to gather 'real-world data'. This means looking at how radiotherapy is actually used in clinics every day, rather than in a controlled experiment. By understanding how different patients respond and how radiotherapy is combined with other treatments, researchers can get a clearer picture of its effectiveness and how it contributes to overall cancer care. This information is vital for improving treatments in the future.

This study is not testing a new medication or treatment. Instead, it's observing and collecting data from patients who are already receiving their standard cancer care. The insights gained from thousands of patients will help doctors and scientists make better decisions about radiotherapy, ensuring that it is used in the most effective way possible to help people with cancer.

Key takeaways

The study collects information about radiotherapy for cancer patients.
It helps researchers understand real-world treatment more effectively.
Your cancer treatment will not change if you take part.
No extra clinic visits or new medications are involved.
Your information helps improve future cancer care for others.
You can choose to leave the study at any time.

Who may be eligible?

To be part of this study, you need to have a confirmed diagnosis of cancer. This means your doctor has definitely identified you have cancer.

You also need to be planning to have radiotherapy as part of your treatment. The study is looking specifically at how radiotherapy is used.

Finally, you need to be at least 12 years old. Importantly, you'll need to give your permission (called 'informed consent') after understanding what the study is about.

Quick self-check

Do you have a confirmed cancer diagnosis?
Is radiotherapy part of your planned cancer treatment?
Are you 12 years old or older?
Are you willing to give your permission to share your medical information for research?

This is a guide only — the research team will confirm whether you can take part.

What does participation involve?

Taking part in the E²-RADIatE study is quite straightforward because it doesn't involve any changes to your usual cancer treatment or extra medical appointments. You won't be given any new medications or experimental treatments. Instead, the study will collect information from your existing medical records about your cancer, the radiotherapy you receive, and how you are progressing over time. You won't need to attend extra visits specifically for the study. The information collected will be from your standard care and will help researchers learn about real-world treatment outcomes. The total duration of your participation will depend on how long the researchers choose to follow your progress, but it won't add any burden to your ongoing medical care.

Potential risks and benefits

Since this study only involves collecting information from your existing medical records and does not change your treatment, there are no direct medical risks to you. You won't be given any new drugs or procedures. The main benefit is that the information gathered from your journey, combined with that of many other patients, will help researchers understand and improve future cancer care for people receiving radiotherapy across Europe. This could lead to better treatments and outcomes for others. You are free to withdraw from the study at any time without affecting your medical treatment.

Locations (77)

Medical University of Graz - Radio-oncology
Graz, Austria· Recruiting
Ordensklinikum Linz-Barmherzige Schwestern
Linz, Austria· Recruiting
Universitaetskliniken der Uni Wien - Universitaetsklinikum Wien - AKH unikliniken
Vienna, Austria· Recruiting
Onze Lieve Vrouw Ziekenhuis
Aalst, Belgium· Suspended
Cliniques Universitaires Saint-Luc
Brussels, Belgium· Recruiting
Institut Jules Bordet
Brussels, Belgium· Recruiting
Universitair Ziekenhuis Gent
Ghent, Belgium· Recruiting
AZ Sint-Lucas & Volkskliniek
Ghent, Belgium· Recruiting
AZ Groeninge Kortrijk - Campus Kennedylaan
Kortrijk, Belgium· Recruiting
U.Z. Leuven - Campus Gasthuisberg
Leuven, Belgium· Suspended
C.H.U. Sart-Tilman
Liège, Belgium· Suspended
CHU Site Sainte-Elisabeth-UCL Namur
Namur, Belgium· Suspended

+65 more sites — see the official record for the full list.

Common questions

Will my treatment change if I join this study?

No, joining this study will not change your cancer treatment in any way. You will still receive the same care as planned by your doctors.

Do I need extra appointments for this study?

No, you will not need to attend any extra appointments or clinics specifically for this study.

What kind of information will be collected?

The study will collect information from your medical records about your cancer diagnosis, your radiotherapy treatment, and how you are doing over time.

Is my personal information kept private?

Yes, any information collected will be handled carefully to protect your privacy and used only for research purposes, following strict rules.

Can I decide not to take part or leave the study later?

Yes, you are completely free to decide not to take part, or to leave the study at any time, without it affecting your medical care.

How to find out more

EORTC HQ

1811@eortc.org +32 2 774 1611 Official trial record

Always speak to your GP or specialist before deciding to take part in a study.